Uday Baldota | Association for Accessible Medicines
In the News - View AAM CEO Dan Leonard's blog on the essential role generic drugs play during COVID-19

Uday Baldota

AAM Board Member
Chief Executive Officer of Taro Pharmaceuticals, a subsidiary of Sun Pharmaceutical Industries, Inc.
Uday Baldota
Uday Baldota
Sun Pharmaceutical Industries, Inc.

Uday Baldota serves as CEO of Taro Pharmaceuticals*. He has over 20 years of management experience, a significant portion of which has been with Sun.

In addition to holding various leadership positions, Uday has been an integral part of Sun’s worldwide growth – including leading several important acquisitions and integrations, most recently that of Ranbaxy.

Uday has both an MBA from the Indian Institute of Management, Ahmedabad and a Chemical Engineering degree from the Indian Institute of Technology, Delhi.​

*a subsidiary of Sun Pharmaceutical Industries, Inc.

Latest Tweets

Association for Accessible Medicines

202.249.7100

Sign-up for Updates

Receive relevant industry news, event information and the latest resources on biosimilars and generic medicines.

Stay Connected

For the latest updates, follow us on social media.